Search

everythinglearnresearchcommunity

for

Search:↓

Hyperandrogenism in women affects skin and quality of life, but treatment is complex due to lack of guidelines.

COVID-19 can cause temporary hair loss due to stress and inflammation.

Certain factors can trigger hormonal imbalances and cyst formation, leading to Polycystic Ovarian Syndrome (PCOS).

Male hormones can decrease the ability of immune cells to fight bacteria.

Eyelashes are important for looks and eye protection, and more people are treating sparse eyelashes; more research is needed to understand eyelash biology and improve treatments.

The hormonal contraceptive combination effectively reduces androgen excess and improves PCOS symptoms like acne, hair loss, and menstrual issues.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Eating dairy and high glycemic foods may increase the risk of acne.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Balding in men worsens with age.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Androgenetic alopecia can cause distress and lower quality of life.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Human skin can produce steroids from cholesterol.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.